🎉 M&A multiples are live!
Check it out!

YSB Valuation Multiples

Discover revenue and EBITDA valuation multiples for YSB and similar public comparables like Brasil Pharma, Sigma Healthcare, and MedPlus India.

YSB Overview

About YSB

YSB Inc is a digital pharmaceutical platform serving businesses outside of hospitals in China. The Group mainly engaged in i) wholesales of pharmaceutical and healthcare products offline or online through its online platform; ii) retail of pharmaceutical and healthcare products through its retail shops; iii) operating online platform that enable the pharmaceutical distributors and vendors to sell their own pharmaceutical and healthcare products using the Group’s online platform; iv) providing SaaS solution to downstream pharmacies to streamline their inventory management; and v) providing medical testing services to primary healthcare institutions. The Group principally operates in the PRC and generates the majority of its revenues from the PRC.


Founded

2018

HQ

Hong Kong
Employees

6.8K+

Website

ysbang.cn

Financials

LTM Revenue $3.1B

LTM EBITDA $30.3M

EV

$685M

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

YSB Financials

As of September 2025, YSB reported last 12-month revenue of $3.1B and EBITDA of $30.3M.

In the same period, YSB generated $314M in LTM gross profit and $20.2M in net income.

See YSB valuation multiples based on analyst estimates

YSB P&L

In the most recent fiscal year, YSB reported revenue of $2.3B and EBITDA of $19.8M.

YSB expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See YSB valuation multiples based on analyst estimates
LTM NTM Last FY FY 2025 FY 2026 FY 2027
Revenue $3.1B XXX $2.3B XXX XXX XXX
Gross Profit $314M XXX $233M XXX XXX XXX
Gross Margin 10% XXX 10% XXX XXX XXX
EBITDA $30.3M XXX $19.8M XXX XXX XXX
EBITDA Margin 1% XXX 1% XXX XXX XXX
EBIT $20.3M XXX -$10.7M XXX XXX XXX
EBIT Margin 1% XXX 0% XXX XXX XXX
Net Profit $20.2M XXX $1.9M XXX XXX XXX
Net Margin 1% XXX 0% XXX XXX XXX
Net Debt XXX XXX n/a XXX XXX XXX

Financial data powered by Morningstar, Inc.

YSB Stock Performance

YSB has current market cap of HKD 7.1B (or $919M), and EV of HKD 5.3B (or $685M).

Market Cap Evolution

YSB Stock Data

As of October 17, 2025, YSB's stock price is HKD 11 (or $1).

See YSB trading valuation data
EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$685M $919M XXX XXX XXX XXX $0.03

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

YSB Valuation Multiples

YSB's trades at 0.3x EV/Revenue multiple, and 34.5x EV/EBITDA.

See valuation multiples for YSB and 15K+ public comps

YSB Financial Valuation Multiples

As of October 17, 2025, YSB has market cap of $919M and EV of $685M.

Equity research analysts estimate YSB's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

YSB has a P/E ratio of 49.6x.

LTM NTM Last FY FY 2025 FY 2026 FY 2027
Market cap (current) $919M XXX $919M XXX XXX XXX
EV (current) $685M XXX $685M XXX XXX XXX
EV/Revenue 0.2x XXX 0.3x XXX XXX XXX
EV/EBITDA 24.7x XXX 34.5x XXX XXX XXX
EV/EBIT 36.8x XXX -63.8x XXX XXX XXX
EV/Gross Profit 2.4x XXX n/a XXX XXX XXX
P/E 49.6x XXX 474.0x XXX XXX XXX
EV/FCF n/a XXX 8.4x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get YSB Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

YSB Margins & Growth Rates

YSB's last 12 month revenue growth is 15%

YSB's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $36K for the same period.

YSB's rule of 40 is -4% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

YSB's rule of X is 37% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for YSB and other 15K+ public comps

YSB Operational Valuation Multiples

LTM NTM Last FY FY 2025 FY 2026 FY 2027
Revenue Growth 15% XXX 20% XXX XXX XXX
EBITDA Margin 1% XXX 1% XXX XXX XXX
EBITDA Growth 74% XXX n/a XXX XXX XXX
Rule of 40 -4% XXX 15% XXX XXX XXX
Bessemer Rule of X XXX XXX 37% XXX XXX XXX
Revenue per Employee XXX XXX $0.3M XXX XXX XXX
Opex per Employee XXX XXX $36K XXX XXX XXX
S&M Expenses to Revenue XXX XXX 8% XXX XXX XXX
G&A Expenses to Revenue XXX XXX n/a XXX XXX XXX
R&D Expenses to Revenue XXX XXX 1% XXX XXX XXX
Opex to Revenue XXX XXX 11% XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

YSB Public Comps

See public comps and valuation multiples for Pharmacies and Vertical E-commerce comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Sigma Healthcare XXX XXX XXX XXX XXX XXX
MedPlus India XXX XXX XXX XXX XXX XXX
SC Ropharma XXX XXX XXX XXX XXX XXX
Brasil Pharma XXX XXX XXX XXX XXX XXX
D1000 Varejo Farma XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

YSB M&A and Investment Activity

YSB acquired  XXX companies to date.

Last acquisition by YSB was  XXXXXXXX, XXXXX XXXXX XXXXXX . YSB acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by YSB

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 65K+ M&A deals.

Start Free Trial

About YSB

When was YSB founded? YSB was founded in 2018.
Where is YSB headquartered? YSB is headquartered in Hong Kong.
How many employees does YSB have? As of today, YSB has 6.8K+ employees.
Who is the CEO of YSB? YSB's CEO is Mr. Buzhen Zhang.
Is YSB publicy listed? Yes, YSB is a public company listed on HKG.
What is the stock symbol of YSB? YSB trades under 09885 ticker.
When did YSB go public? YSB went public in 2023.
Who are competitors of YSB? Similar companies to YSB include e.g. Sigma Healthcare, MedPlus India, SC Ropharma, Brasil Pharma.
What is the current market cap of YSB? YSB's current market cap is $919M
What is the current revenue of YSB? YSB's last 12 months revenue is $3.1B.
What is the current revenue growth of YSB? YSB revenue growth (NTM/LTM) is 15%.
What is the current EV/Revenue multiple of YSB? Current revenue multiple of YSB is 0.2x.
Is YSB profitable? Yes, YSB is EBITDA-positive (as of the last 12 months).
What is the current EBITDA of YSB? YSB's last 12 months EBITDA is $30.3M.
What is YSB's EBITDA margin? YSB's last 12 months EBITDA margin is 1%.
What is the current EV/EBITDA multiple of YSB? Current EBITDA multiple of YSB is 24.7x.

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.